Cargando…
Use of real world data to improve drug coverage decisions in China
Wen Wang and colleagues discuss the rationale and propose a framework for using real world evidence to support coverage decisions in Chinese setting
Autores principales: | Wang, Wen, Tan, Jing, Wu, Jing, Huang, Shiyao, Huang, Yunxiang, Xie, Feng, Sun, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266438/ https://www.ncbi.nlm.nih.gov/pubmed/37321633 http://dx.doi.org/10.1136/bmj-2021-068911 |
Ejemplares similares
-
Real world evidence: experience and lessons from China
por: Sun, Xin, et al.
Publicado: (2018) -
Use of health technology assessment in drug reimbursement decisions in China
por: Chen, Wen, et al.
Publicado: (2023) -
Universal health coverage, health systems strengthening, and the World Bank
por: Tichenor, Marlee, et al.
Publicado: (2017) -
Towards universal health coverage: achievements and challenges of 10 years of healthcare reform in China
por: Tao, Wenjuan, et al.
Publicado: (2020) -
Strengthening public health services to achieve universal health coverage in China
por: Yuan, Beibei, et al.
Publicado: (2019)